Mentoring Faculty in the ADRD Training Program

Mentors1

The ADRD Training Program has enlisted the participation of the following faculty as Mentors, due to their expertise in the following fields:

  • Cellular, computational & animal modeling of addiction, aging, hypoxia, AD, FTD, ALS, & PD
  • Neurodegeneration & inflammation
  • Cognition & aging
  • Addiction, psychiatric & behavioral disorders, sleep & hypoxia
  • Neuropathology & neuroimaging
  • Genetics, RNA biology & viral transduction
  • Use of large-scale, open-format databases
  • Clinical diagnostics, clinical neuropsychology & behavioral interventions of AD & overlapping conditions

Andrew Maurer, PhD

Understanding how the brain rapidly translates environmental information into complex representations in support of cognitive function.

maurer

Gordon Mitchell, PhD

Identifying fundamental mechanisms of spinal respiratory motor plasticity induced by intermittent hypoxia, and attempts to harness that plasticity to treat devastating clinical disorders that compromise breathing and non-respiratory limb movements, such as cervical spinal injury and ALS.

Gordon Mitchell

Catherine Price, PhD

Examining the predictive value of patients’ white and gray matter structure integrity on disease associated cognitive decline and vulnerability to cognitive change after elective medical interventions with anesthesia.

Catherine Price

Diego Rincon-Limas, PhD

Development and application of new technologies to define the molecular pathways leading to neurodegeneration and identification of potential therapeutic targets

diego-rincon-limas

Maurice Swanson, PhD

How RNA processing is regulated during embryonic, fetal and postnatal development and how this regulation is disrupted in neurological disease, particularly in microsatellite expansion disorders.

Swanson

Eric Wang, PhD

His lab is focused on three main areas – 1) studying the pathogenesis of microsatellite repeat diseases, in particular myotonic dystrophy, 2) studying the basics of how RNA is processed and localized in cells in tissues, and 3) combining insights made in both of those areas to develop treatments for people with these diseases.

eric_wang

Daniel Wesson, PhD

Testing specific hypotheses regarding the neural basis of sensory dysfunction in neurological disorders, including dementias and addiction, wherein sensory processing is aberrant.

Daniel Wesson